LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Second-line hope for liver cancer: regorafenib tested after lenvatinib failure
Disease control Not yet recruitingThis study tests a drug called regorafenib in about 24 adults with advanced liver cancer that did not respond to the first treatment, lenvatinib. The goal is to see if regorafenib can slow tumor growth and improve survival. Participants will take regorafenib pills and have regula…
Matched conditions: LENVATINIB
Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New triple therapy targets hard-to-treat bile duct cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (disitamab vedotin, lenvatinib, and a PD-1 inhibitor) in 65 adults with advanced HER2-positive bile duct cancer that cannot be removed by surgery. The goal is to see how well the treatment shrinks tumors and how safe it is. Participan…
Matched conditions: LENVATINIB
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
AI reads liver cancer slides to personalize Post-Surgery care
Knowledge-focused Not yet recruitingThis study aims to build an AI tool that analyzes standard tissue images from liver cancer patients after surgery. The goal is to predict who will benefit from additional treatments like chemotherapy or targeted drugs. Researchers will use data from 1,000 patients across multiple…
Matched conditions: LENVATINIB
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC